{"id":"https://openalex.org/W2022106950","doi":"https://doi.org/10.1067/mcp.2002.126182","title":"Comparison of rofecoxib, celecoxib, and naproxen on renal function in elderly subjects receiving a normal\u2010salt diet","display_name":"Comparison of rofecoxib, celecoxib, and naproxen on renal function in elderly subjects receiving a normal\u2010salt diet","publication_year":2002,"publication_date":"2002-07-01","ids":{"openalex":"https://openalex.org/W2022106950","doi":"https://doi.org/10.1067/mcp.2002.126182","mag":"2022106950","pmid":"https://pubmed.ncbi.nlm.nih.gov/12152004"},"language":"en","primary_location":{"id":"doi:10.1067/mcp.2002.126182","doi":"https://doi.org/10.1067/mcp.2002.126182","is_oa":false,"landing_page_url":"https://doi.org/10.1067/mcp.2002.126182","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology &amp; Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2022106950"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029778884","display_name":"Jules I. Schwartz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]},{"id":"https://openalex.org/I181369854","display_name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","ror":"https://ror.org/00f7hpc57","country_code":"DE","type":"education","lineage":["https://openalex.org/I181369854"]}],"countries":["DE","US"],"is_corresponding":true,"raw_author_name":"J. I. Schwartz","raw_affiliation_strings":["Clinical Pharmacology Associates and SFBC-International, Miami, Fla","Merck Research Laboratories, Rahway and Brussels, NJ and Belgium","University Erlangen, Erlangen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology Associates and SFBC-International, Miami, Fla","institution_ids":[]},{"raw_affiliation_string":"Merck Research Laboratories, Rahway and Brussels, NJ and Belgium","institution_ids":["https://openalex.org/I1285764155"]},{"raw_affiliation_string":"University Erlangen, Erlangen, Germany","institution_ids":["https://openalex.org/I181369854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111943644","display_name":"K. Vandormael","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]},{"id":"https://openalex.org/I181369854","display_name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","ror":"https://ror.org/00f7hpc57","country_code":"DE","type":"education","lineage":["https://openalex.org/I181369854"]}],"countries":["DE","US"],"is_corresponding":false,"raw_author_name":"K. Vandormael","raw_affiliation_strings":["Clinical Pharmacology Associates and SFBC-International, Miami, Fla","Merck Research Laboratories, Rahway and Brussels, NJ and Belgium","University Erlangen, Erlangen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology Associates and SFBC-International, Miami, Fla","institution_ids":[]},{"raw_affiliation_string":"Merck Research Laboratories, Rahway and Brussels, NJ and Belgium","institution_ids":["https://openalex.org/I1285764155"]},{"raw_affiliation_string":"University Erlangen, Erlangen, Germany","institution_ids":["https://openalex.org/I181369854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037637167","display_name":"Marie\u2010Pierre Malice","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]},{"id":"https://openalex.org/I181369854","display_name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","ror":"https://ror.org/00f7hpc57","country_code":"DE","type":"education","lineage":["https://openalex.org/I181369854"]}],"countries":["DE","US"],"is_corresponding":false,"raw_author_name":"M. P. Malice","raw_affiliation_strings":["Clinical Pharmacology Associates and SFBC-International, Miami, Fla","Merck Research Laboratories, Rahway and Brussels, NJ and Belgium","University Erlangen, Erlangen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology Associates and SFBC-International, Miami, Fla","institution_ids":[]},{"raw_affiliation_string":"Merck Research Laboratories, Rahway and Brussels, NJ and Belgium","institution_ids":["https://openalex.org/I1285764155"]},{"raw_affiliation_string":"University Erlangen, Erlangen, Germany","institution_ids":["https://openalex.org/I181369854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061207173","display_name":"Rubana N. Kalyani","orcid":"https://orcid.org/0000-0003-1198-3391","observed_orcids":["https://orcid.org/0000-0003-1198-3391"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]},{"id":"https://openalex.org/I181369854","display_name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","ror":"https://ror.org/00f7hpc57","country_code":"DE","type":"education","lineage":["https://openalex.org/I181369854"]}],"countries":["DE","US"],"is_corresponding":false,"raw_author_name":"R. N. Kalyani","raw_affiliation_strings":["Clinical Pharmacology Associates and SFBC-International, Miami, Fla","Merck Research Laboratories, Rahway and Brussels, NJ and Belgium","University Erlangen, Erlangen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology Associates and SFBC-International, Miami, Fla","institution_ids":[]},{"raw_affiliation_string":"Merck Research Laboratories, Rahway and Brussels, NJ and Belgium","institution_ids":["https://openalex.org/I1285764155"]},{"raw_affiliation_string":"University Erlangen, Erlangen, Germany","institution_ids":["https://openalex.org/I181369854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061427649","display_name":"Kenneth C. Lasseter","orcid":"https://orcid.org/0000-0001-8175-2199","observed_orcids":["https://orcid.org/0000-0001-8175-2199"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]},{"id":"https://openalex.org/I181369854","display_name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","ror":"https://ror.org/00f7hpc57","country_code":"DE","type":"education","lineage":["https://openalex.org/I181369854"]}],"countries":["DE","US"],"is_corresponding":false,"raw_author_name":"K. C. Lasseter","raw_affiliation_strings":["Clinical Pharmacology Associates and SFBC-International, Miami, Fla","Merck Research Laboratories, Rahway and Brussels, NJ and Belgium","University Erlangen, Erlangen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology Associates and SFBC-International, Miami, Fla","institution_ids":[]},{"raw_affiliation_string":"Merck Research Laboratories, Rahway and Brussels, NJ and Belgium","institution_ids":["https://openalex.org/I1285764155"]},{"raw_affiliation_string":"University Erlangen, Erlangen, Germany","institution_ids":["https://openalex.org/I181369854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109558091","display_name":"Gregory B. Holmes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]},{"id":"https://openalex.org/I181369854","display_name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","ror":"https://ror.org/00f7hpc57","country_code":"DE","type":"education","lineage":["https://openalex.org/I181369854"]}],"countries":["DE","US"],"is_corresponding":false,"raw_author_name":"G. B. Holmes","raw_affiliation_strings":["Clinical Pharmacology Associates and SFBC-International, Miami, Fla","Merck Research Laboratories, Rahway and Brussels, NJ and Belgium","University Erlangen, Erlangen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology Associates and SFBC-International, Miami, Fla","institution_ids":[]},{"raw_affiliation_string":"Merck Research Laboratories, Rahway and Brussels, NJ and Belgium","institution_ids":["https://openalex.org/I1285764155"]},{"raw_affiliation_string":"University Erlangen, Erlangen, Germany","institution_ids":["https://openalex.org/I181369854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113576921","display_name":"B. J. Gertz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]},{"id":"https://openalex.org/I181369854","display_name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","ror":"https://ror.org/00f7hpc57","country_code":"DE","type":"education","lineage":["https://openalex.org/I181369854"]}],"countries":["DE","US"],"is_corresponding":false,"raw_author_name":"B. J. Gertz","raw_affiliation_strings":["Clinical Pharmacology Associates and SFBC-International, Miami, Fla","Merck Research Laboratories, Rahway and Brussels, NJ and Belgium","University Erlangen, Erlangen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology Associates and SFBC-International, Miami, Fla","institution_ids":[]},{"raw_affiliation_string":"Merck Research Laboratories, Rahway and Brussels, NJ and Belgium","institution_ids":["https://openalex.org/I1285764155"]},{"raw_affiliation_string":"University Erlangen, Erlangen, Germany","institution_ids":["https://openalex.org/I181369854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026975469","display_name":"Keith M Gottesdiener","orcid":"https://orcid.org/0000-0001-9121-2145","observed_orcids":["https://orcid.org/0000-0001-9121-2145"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]},{"id":"https://openalex.org/I181369854","display_name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","ror":"https://ror.org/00f7hpc57","country_code":"DE","type":"education","lineage":["https://openalex.org/I181369854"]}],"countries":["DE","US"],"is_corresponding":false,"raw_author_name":"K. M. Gottesdiener","raw_affiliation_strings":["Clinical Pharmacology Associates and SFBC-International, Miami, Fla","Merck Research Laboratories, Rahway and Brussels, NJ and Belgium","University Erlangen, Erlangen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology Associates and SFBC-International, Miami, Fla","institution_ids":[]},{"raw_affiliation_string":"Merck Research Laboratories, Rahway and Brussels, NJ and Belgium","institution_ids":["https://openalex.org/I1285764155"]},{"raw_affiliation_string":"University Erlangen, Erlangen, Germany","institution_ids":["https://openalex.org/I181369854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088216487","display_name":"Martino W. Laurenzi","orcid":"https://orcid.org/0000-0002-5470-2628","observed_orcids":["https://orcid.org/0000-0002-5470-2628"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]},{"id":"https://openalex.org/I181369854","display_name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","ror":"https://ror.org/00f7hpc57","country_code":"DE","type":"education","lineage":["https://openalex.org/I181369854"]}],"countries":["DE","US"],"is_corresponding":false,"raw_author_name":"M. Laurenzi","raw_affiliation_strings":["Clinical Pharmacology Associates and SFBC-International, Miami, Fla","Merck Research Laboratories, Rahway and Brussels, NJ and Belgium","University Erlangen, Erlangen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology Associates and SFBC-International, Miami, Fla","institution_ids":[]},{"raw_affiliation_string":"Merck Research Laboratories, Rahway and Brussels, NJ and Belgium","institution_ids":["https://openalex.org/I1285764155"]},{"raw_affiliation_string":"University Erlangen, Erlangen, Germany","institution_ids":["https://openalex.org/I181369854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108084215","display_name":"K.\u2010J. Redfern","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]},{"id":"https://openalex.org/I181369854","display_name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","ror":"https://ror.org/00f7hpc57","country_code":"DE","type":"education","lineage":["https://openalex.org/I181369854"]}],"countries":["DE","US"],"is_corresponding":false,"raw_author_name":"K.\u2010J. Redfern","raw_affiliation_strings":["Clinical Pharmacology Associates and SFBC-International, Miami, Fla","Merck Research Laboratories, Rahway and Brussels, NJ and Belgium","University Erlangen, Erlangen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology Associates and SFBC-International, Miami, Fla","institution_ids":[]},{"raw_affiliation_string":"Merck Research Laboratories, Rahway and Brussels, NJ and Belgium","institution_ids":["https://openalex.org/I1285764155"]},{"raw_affiliation_string":"University Erlangen, Erlangen, Germany","institution_ids":["https://openalex.org/I181369854"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5027292872","display_name":"Kay Brune","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]},{"id":"https://openalex.org/I181369854","display_name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","ror":"https://ror.org/00f7hpc57","country_code":"DE","type":"education","lineage":["https://openalex.org/I181369854"]}],"countries":["DE","US"],"is_corresponding":false,"raw_author_name":"K. Brune","raw_affiliation_strings":["Clinical Pharmacology Associates and SFBC-International, Miami, Fla","Merck Research Laboratories, Rahway and Brussels, NJ and Belgium","University Erlangen, Erlangen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology Associates and SFBC-International, Miami, Fla","institution_ids":[]},{"raw_affiliation_string":"Merck Research Laboratories, Rahway and Brussels, NJ and Belgium","institution_ids":["https://openalex.org/I1285764155"]},{"raw_affiliation_string":"University Erlangen, Erlangen, Germany","institution_ids":["https://openalex.org/I181369854"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5029778884"],"corresponding_institution_ids":["https://openalex.org/I1285764155","https://openalex.org/I181369854"],"apc_list":{"value":4410,"currency":"USD","value_usd":4410},"apc_paid":null,"fwci":10.525,"has_fulltext":false,"cited_by_count":164,"citation_normalized_percentile":{"value":0.98727438,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"72","issue":"1","first_page":"50","last_page":"61"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.9833999872207642,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.9833999872207642,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12910","display_name":"Eicosanoids and Hypertension Pharmacology","score":0.0044999998062849045,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12075","display_name":"Sodium Intake and Health","score":0.002400000113993883,"subfield":{"id":"https://openalex.org/subfields/2916","display_name":"Nutrition and Dietetics"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rofecoxib","display_name":"rofecoxib","score":0.9819999933242798},{"id":"https://openalex.org/keywords/celecoxib","display_name":"celecoxib","score":1.0},{"id":"https://openalex.org/keywords/naproxen","display_name":"naproxen","score":1.0},{"id":"https://openalex.org/keywords/cox-2-inhibitors","display_name":"COX-2 inhibitors","score":0.8960000276565552},{"id":"https://openalex.org/keywords/nonsteroidal-anti-inflammatory-drugs","display_name":"nonsteroidal anti-inflammatory drugs","score":0.8830000162124634},{"id":"https://openalex.org/keywords/renal-function","display_name":"renal function","score":0.9539999961853027},{"id":"https://openalex.org/keywords/sodium-excretion","display_name":"sodium excretion","score":0.9810000061988831},{"id":"https://openalex.org/keywords/elderly-subjects","display_name":"elderly subjects","score":0.7639999985694885},{"id":"https://openalex.org/keywords/blood-pressure","display_name":"blood pressure","score":0.7039999961853027},{"id":"https://openalex.org/keywords/creatinine-clearance","display_name":"creatinine clearance","score":0.6919999718666077},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.33899998664855957},{"id":"https://openalex.org/keywords/non-selective-nsaids","display_name":"non-selective NSAIDs","score":0.4880000054836273},{"id":"https://openalex.org/keywords/healthy-volunteers","display_name":"healthy volunteers","score":0.4869999885559082},{"id":"https://openalex.org/keywords/placebo-controlled-comparison","display_name":"placebo comparison","score":0.4390000104904175},{"id":"https://openalex.org/keywords/cyclooxygenase","display_name":"cyclooxygenase","score":0.6700000166893005}],"concepts":[{"id":"https://openalex.org/C2778582115","wikidata":"https://www.wikidata.org/wiki/Q411412","display_name":"Rofecoxib","level":4,"score":0.9852440357208252},{"id":"https://openalex.org/C2776467144","wikidata":"https://www.wikidata.org/wiki/Q408801","display_name":"Celecoxib","level":2,"score":0.9005541801452637},{"id":"https://openalex.org/C2778115740","wikidata":"https://www.wikidata.org/wiki/Q1215575","display_name":"Naproxen","level":3,"score":0.7063249349594116},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7005840539932251},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.669001042842865},{"id":"https://openalex.org/C2909752691","wikidata":"https://www.wikidata.org/wiki/Q1215575","display_name":"Naproxen Sodium","level":4,"score":0.6424561142921448},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.5236584544181824},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47241321206092834},{"id":"https://openalex.org/C10146269","wikidata":"https://www.wikidata.org/wiki/Q185557","display_name":"Excretion","level":2,"score":0.4549798369407654},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.42049479484558105},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3576744496822357},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.32839861512184143},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3210863173007965},{"id":"https://openalex.org/C2779689624","wikidata":"https://www.wikidata.org/wiki/Q410251","display_name":"Cyclooxygenase","level":3,"score":0.2628170847892761},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.14702779054641724},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000068579","descriptor_name":"Celecoxib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001835","descriptor_name":"Body Weight","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003404","descriptor_name":"Creatinine","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D004032","descriptor_name":"Diet","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004573","descriptor_name":"Electrolytes","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007668","descriptor_name":"Kidney","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D007783","descriptor_name":"Lactones","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009288","descriptor_name":"Naproxen","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D011188","descriptor_name":"Potassium","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012964","descriptor_name":"Sodium","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D013450","descriptor_name":"Sulfones","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016861","descriptor_name":"Cyclooxygenase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D017673","descriptor_name":"Sodium Chloride, Dietary","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1067/mcp.2002.126182","doi":"https://doi.org/10.1067/mcp.2002.126182","is_oa":false,"landing_page_url":"https://doi.org/10.1067/mcp.2002.126182","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology &amp; Therapeutics","raw_type":"journal-article"},{"id":"pmid:12152004","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12152004","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacology and therapeutics","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2146625461","https://openalex.org/W3122245833","https://openalex.org/W2107864895","https://openalex.org/W4408572725","https://openalex.org/W2162491093","https://openalex.org/W2042274378","https://openalex.org/W1992111716","https://openalex.org/W2064412700","https://openalex.org/W2072197739","https://openalex.org/W2018715887"],"abstract_inverted_index":{"BACKGROUND:":[0],"This":[1],"study":[2],"compared":[3,132],"directly":[4],"the":[5,41,98,101,107,116,155,261,276],"renal":[6,294],"effects":[7],"of":[8,35,120,157,199,242,263],"two":[9],"selective":[10],"cyclooxygenase":[11],"(COX)-2":[12],"inhibitors":[13,278],"(rofecoxib":[14],"and":[15,22,45,129,140,165,172,185,211,230,280,303],"celecoxib)":[16],"with":[17,133,151,248],"naproxen":[18,130,167,173],"(dual":[19],"COX-1/COX-2":[20],"inhibitor)":[21],"placebo":[23,87],"in":[24,40,56,97,126,143,205,225,292],"healthy":[25,269],"elderly":[26,37,270],"subjects":[27,38,271],"on":[28,48,106,154,272],"a":[29,49,57,180,273,286],"sodium-replete":[30,274],"diet.":[31,109],"METHODS:":[32],"A":[33],"total":[34],"67":[36],"stabilized":[39],"clinic":[42,99],"for":[43,91,100,194,220],"weight":[44,310],"urinary":[46,112,144,231,299],"sodium":[47,52,113,145,300],"controlled":[50,108],"200-mEq":[51],"diet":[53],"were":[54,95,149,237,245],"randomized":[55],"double-blind":[58],"fashion":[59],"to":[60,166,179],"receive":[61],"rofecoxib,":[62,127],"25":[63],"mg":[64,71,79],"daily":[65,73,81],"(n":[66,74,82,88],"=":[67,75,83,89],"17);":[68,76,84],"celecoxib,":[69,128,171],"200":[70],"twice":[72,80],"naproxen,":[77],"500":[78],"or":[85,137,257,309],"matching":[86],"16)":[90],"28":[92,240],"days.":[93,252],"Subjects":[94],"sequestered":[96],"first":[102,117],"14":[103,197,251],"treatment":[104,121,259],"days":[105,198,241],"RESULTS:":[110],"Daily":[111],"excretion":[114,146,233],"during":[115],"72":[118],"hours":[119],"(primary":[122],"endpoint)":[123],"significantly":[124],"decreased":[125],"groups":[131],"baseline":[134,224],"(P":[135],"<":[136],"=.05).":[138],"Rofecoxib":[139],"celecoxib":[141,281],"decreases":[142],"rates":[147],"that":[148],"comparable":[150],"each":[152],"other,":[153],"basis":[156],"predefined":[158],"boundaries":[159],"(-39.5":[160],"versus":[161,190,216],"-27.1":[162],"mEq/d,":[163],"respectively)":[164],"(-40.6,":[168],"mEq/d).":[169],"Rofecoxib,":[170],"increased":[174],"mean":[175],"systolic":[176,302],"blood":[177,207,305],"pressure":[178,208],"similar":[181],"degree":[182],"(3.4,":[183],"4.3,":[184],"3.1":[186],"mm":[187,192,213,218],"Hg,":[188,214],"respectively,":[189,215],"-1.3":[191],"Hg":[193,219],"placebo)":[195],"after":[196],"treatment;":[200],"small":[201],"changes":[202],"also":[203],"occurred":[204],"diastolic":[206,304],"(0.3,":[209],"0.8,":[210],"-0.4":[212],"-1.4":[217],"placebo).":[221],"Changes":[222],"from":[223,285],"creatinine":[226,307],"clearance,":[227,308],"body":[228],"weight,":[229],"potassium":[232],"among":[234],"active":[235],"treatments":[236],"similar.":[238],"After":[239],"treatment,":[243],"findings":[244],"generally":[246],"consistent":[247],"those":[249],"at":[250],"No":[253],"subject":[254],"reported":[255],"edema":[256],"discontinued":[258],"as":[260,296],"result":[262],"an":[264],"adverse":[265],"experience.":[266],"CONCLUSION:":[267],"In":[268],"diet,":[275],"COX-2":[277],"rofecoxib":[279],"did":[282],"not":[283],"differ":[284],"nonselective":[287],"nonsteroidal":[288],"anti-inflammatory":[289],"drug":[290],"(naproxen),":[291],"influencing":[293],"function":[295],"measured":[297],"by":[298],"excretion,":[301],"pressure,":[306],"change.":[311]},"counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":10}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
